NO993085L - 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon - Google Patents

3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon

Info

Publication number
NO993085L
NO993085L NO993085A NO993085A NO993085L NO 993085 L NO993085 L NO 993085L NO 993085 A NO993085 A NO 993085A NO 993085 A NO993085 A NO 993085A NO 993085 L NO993085 L NO 993085L
Authority
NO
Norway
Prior art keywords
aryl
lower alkyl
acyl
hydrogen
piperidinyl
Prior art date
Application number
NO993085A
Other languages
English (en)
Other versions
NO993085D0 (no
Inventor
Gregory H Merriman
Barbara S Rauckman
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO993085D0 publication Critical patent/NO993085D0/no
Publication of NO993085L publication Critical patent/NO993085L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår 3- aryl-2-(l-substituert-4-piperidinyl)- l ,1-dioxo ¿ 3H-benzo[d]isothiazol- derivater og beslektede forbindelser av formel (I) hvor X og Y er halogen, lavere alkyl, lavere alkoxy, aryl-lavere alkoxy, acyl, hydroxy, nitro, amino, trifluormethyl og hydrogen; n, p og q er uavhengig hele tall på l eller 2; R er hydrogen, lavere alkyl, aryl-lavere alkyl, acyl, ~<CH2)m~ORl' -(CH2)mNHR1, formler (a) og O. ^-^^^-^"^^ (a) (b) hvor R, er hydrogen, lavere alkyl, aryl- lavere alkyl, acyl og lavere alkoxy- carbonyl; Z er hydrogen, halogen, lavere alkyl, lavere alkoxy og acyl; m er et helt tall på 2 til 4; s er et helt tall på l eller 2; og farmasøytisk akseptable syreaddisjonssalter derav og optiske isomertir derav hvor slike isomerer eksisterer. Forbindelsene av formel (I) ifølge foreliggende oppfinnelse er anvendbare som modulatorer av neuro- transmitterfunksjon slik som seroto- nergisk og adrenergisk, og er som sådanne anvendbare som antidepressive midler, og dopaminergisk funksjon, og kan som sådanne være anvendbare for sykdommer hvor potensiering av dopaminerg aktivitet kan være av hjelp, for eksempel Parkinsons sykdom.
NO993085A 1996-12-23 1999-06-22 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon NO993085L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77486696A 1996-12-23 1996-12-23
PCT/US1997/021178 WO1998028295A1 (en) 1996-12-23 1997-11-13 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function

Publications (2)

Publication Number Publication Date
NO993085D0 NO993085D0 (no) 1999-06-22
NO993085L true NO993085L (no) 1999-08-20

Family

ID=25102528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993085A NO993085L (no) 1996-12-23 1999-06-22 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon

Country Status (17)

Country Link
EP (1) EP0956287B1 (no)
JP (1) JP3282827B2 (no)
KR (1) KR20000062283A (no)
AR (1) AR009440A1 (no)
AT (1) ATE247111T1 (no)
AU (1) AU716689B2 (no)
BR (1) BR9714432A (no)
CA (1) CA2273181C (no)
DE (1) DE69724148T2 (no)
DK (1) DK0956287T3 (no)
ES (1) ES2200205T3 (no)
HU (1) HUP9904071A3 (no)
IL (1) IL130605A0 (no)
NO (1) NO993085L (no)
PT (1) PT956287E (no)
WO (1) WO1998028295A1 (no)
ZA (1) ZA9711337B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393351B1 (it) * 2009-03-16 2012-04-20 Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2509797C2 (de) * 1975-03-06 1985-07-18 Dr. Karl Thomae Gmbh, 7950 Biberach Phthalimidine, deren physiologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT345806B (de) * 1975-03-06 1978-10-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer substituierter arylalkylamine und deren salze
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors

Also Published As

Publication number Publication date
PT956287E (pt) 2003-11-28
DE69724148T2 (de) 2004-06-09
EP0956287B1 (en) 2003-08-13
HUP9904071A3 (en) 2000-07-28
AU716689B2 (en) 2000-03-02
AR009440A1 (es) 2000-04-12
CA2273181C (en) 2004-01-20
DK0956287T3 (da) 2003-11-24
IL130605A0 (en) 2000-06-01
WO1998028295A1 (en) 1998-07-02
ATE247111T1 (de) 2003-08-15
KR20000062283A (ko) 2000-10-25
HUP9904071A2 (hu) 2000-05-28
EP0956287A1 (en) 1999-11-17
ZA9711337B (en) 1998-06-23
ES2200205T3 (es) 2004-03-01
AU5358898A (en) 1998-07-17
CA2273181A1 (en) 1998-07-02
JP2001520641A (ja) 2001-10-30
JP3282827B2 (ja) 2002-05-20
NO993085D0 (no) 1999-06-22
DE69724148D1 (de) 2003-09-18
BR9714432A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
US4797130A (en) Oxidative hair dye composition based on 4-amino-2-aminomethyl-phenols
FR2776510B1 (fr) Derives de polyamino-acides et leur utilisation dans des compositions de traitement des fibres keratiniques
MA29649B1 (fr) Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
PT1437123E (pt) Composição de tintura das fibras queratínicas e processo de tintura utilizando esta composição
NO306237B1 (no) Anvendelse av xantinderivater som antidepressive midler
HUP0004439A2 (hu) 1-Helyettesített-1-amino-metil-cikloalkán-származékok (gabapentin analógok), a vegyületek előállítása és neurológiai rendellenességek kezelésében való alkalmazása
DE69503803T2 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
HUP0002348A2 (hu) A bőr mesterséges színezésére szolgáló szantalinokat vagy szantarubinokat tartalmazó kozmetikai készítmények
KR930701434A (ko) 옥사졸리딘 디온 유도체
BR9713126A (pt) Compostos derivados da piridin-2-il-metilamina, processo para sua preparação, compostos intermediários de sìntese, medicamento inédito, e, composição farmacêutica
HUP0303281A2 (hu) Benzodiazepinszármazékok, mint GABA A receptor modulátorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0959906T3 (da) Delta 1,6 bicyclo[4,4,0] funktionelle farver til kontrastforøgelse ved optisk afbildning
HUP0002853A2 (hu) 6,7-Helyzetben aszimmetrikusan diszubsztituált kinoxalinkarbonsav-származékok, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
CA2370805A1 (en) Ureas as cell adhesion modulators
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
HUP0104657A2 (hu) Imidazolvegyületek és ezeket tartalmazó gyógyászati készítmények
TR200103349T2 (tr) Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
NO975094L (no) Vinylpyrrolidoncefalosporinderivater
CA2168937A1 (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
NO993085L (no) 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon
NO20012965L (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
FR2803194A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations
HUP0402585A2 (hu) Új benzotiazin- benzotiadiazin-származékok, előállításuk, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application